CONCLUSION: The majority of patients with HER-2/neu–overexpressing cancers can develop immunity to both HER-2/neu peptides and protein. In addition, the generation of protein-specific immunity, after ...
The MONeT study enrolled individuals who had chronic pulmonary, cardiovascular, renal, hepatic, neurologic, hematologic or metabolic disorders. The Food and Drug Administration (FDA) has approved ...
The Comirnaty 2025-2026 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, a descendant of JN.1. The Food and Drug Administration (FDA) has approved Comirnaty ® (LP.8.1-adapted monovalent ...
In the 1880's and 1890's, Robert Koch established that a different microbe causes each infectious disease. Koch defined a process by which a specific causative organism could be identified by ...
Across the life course, susceptibility and exposure to vaccine-preventable diseases (VPDs) are not static; they change systematically as individuals move ...
In the early 1950s there were four vaccines routinely used in the United States: diphtheria, tetanus, pertussis, and smallpox. Three of these vaccines (diphtheria, tetanus, and pertussis) were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results